PT3149007T - Derivados de alquilo e arilo de compostos de 1-oxa-4,9-diazaespiro undecano tendo atividade multimodal contra a dor - Google Patents

Derivados de alquilo e arilo de compostos de 1-oxa-4,9-diazaespiro undecano tendo atividade multimodal contra a dor

Info

Publication number
PT3149007T
PT3149007T PT157260001T PT15726000T PT3149007T PT 3149007 T PT3149007 T PT 3149007T PT 157260001 T PT157260001 T PT 157260001T PT 15726000 T PT15726000 T PT 15726000T PT 3149007 T PT3149007 T PT 3149007T
Authority
PT
Portugal
Prior art keywords
oxa
alkyl
activity against
aryl derivatives
against pain
Prior art date
Application number
PT157260001T
Other languages
English (en)
Original Assignee
Esteve Pharmaceuticals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Pharmaceuticals Sa filed Critical Esteve Pharmaceuticals Sa
Publication of PT3149007T publication Critical patent/PT3149007T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PT157260001T 2014-06-02 2015-06-02 Derivados de alquilo e arilo de compostos de 1-oxa-4,9-diazaespiro undecano tendo atividade multimodal contra a dor PT3149007T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14382207 2014-06-02

Publications (1)

Publication Number Publication Date
PT3149007T true PT3149007T (pt) 2020-04-16

Family

ID=50972616

Family Applications (1)

Application Number Title Priority Date Filing Date
PT157260001T PT3149007T (pt) 2014-06-02 2015-06-02 Derivados de alquilo e arilo de compostos de 1-oxa-4,9-diazaespiro undecano tendo atividade multimodal contra a dor

Country Status (11)

Country Link
US (2) US10703765B2 (pt)
EP (1) EP3149007B1 (pt)
JP (1) JP6535687B2 (pt)
CN (1) CN106459093A (pt)
AR (1) AR100714A1 (pt)
CA (1) CA2949570A1 (pt)
ES (1) ES2784250T3 (pt)
MX (1) MX2016015762A (pt)
PT (1) PT3149007T (pt)
TW (1) TW201615643A (pt)
WO (1) WO2015185207A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201615643A (zh) 2014-06-02 2016-05-01 伊史帝夫博士實驗室股份有限公司 具有多重模式抗疼痛活性之１－氧雜－４，９－二氮雜螺十一烷化合物之烷基與芳基衍生物
TWI685497B (zh) 2014-06-02 2020-02-21 西班牙商伊史帝夫製藥公司 具有多重模式抗疼痛活性的１-氧雜-４,９-二氮雜螺十一烷化合物之烷基衍生物
TW201615642A (zh) 2014-06-02 2016-05-01 伊史帝夫博士實驗室股份有限公司 具有多重模式抗疼痛活性的１－氧雜－４，９－二氮雜螺十一烷化合物之醯胺衍生物
TW201808921A (zh) * 2015-10-23 2018-03-16 艾斯提夫博士實驗股份有限公司 具有抗疼痛活性之氧雜－氮雜螺環化合物
EP3365346B1 (en) * 2015-10-23 2019-12-04 Esteve Pharmaceuticals, S.A. Oxa-diazaspiro compounds having activity against pain
AR106697A1 (es) * 2015-11-16 2018-02-07 Esteve Labor Dr Compuestos oxadiazoespíricos para el tratamiento del abuso y la adicción a las drogas
CN107216335B (zh) * 2017-06-29 2019-04-30 上海药明康德新药开发有限公司 一种叔丁基1-(羟甲基)-3-氧杂-9-氮杂螺[5.5]十一烷-9-甲酸基酯制法
TW201908295A (zh) * 2017-07-12 2019-03-01 德商歌林達有限公司 １，３－二氮雜－螺－［３．４］－辛烷衍生物
US11236110B2 (en) 2017-10-17 2022-02-01 Esteve Pharmaceuticals, S.A. Salts of (R)-9-(2,5-difluorophenethyl)-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one
WO2019180188A1 (en) * 2018-03-23 2019-09-26 Esteve Pharmaceuticals, S.A. Aminopropoxyphenyl and benzyl 1-oxa-4,9-diazaspiroundecane derivatives having multimodal activity against pain
WO2021018824A1 (en) * 2019-07-31 2021-02-04 Esteve Pharmaceuticals, S.A. Use of (r)-9-(2,5-difluorophenethyl)-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one for the treatment of nociceptive pain, neuropathic pain, osteoarthritis pain and cancer pain, while having reduced side effects compared to opioids
WO2024105225A1 (en) 2022-11-18 2024-05-23 Universitat De Barcelona Synergistic combinations of a sigma receptor 1 (s1r) antagonist and a soluble epoxide hydrolase inhibitor (sehi) and their use in the treatment of pain

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3481942A (en) 1968-09-06 1969-12-02 Smithkline Corp Oxa-diazaspiro(4.5)decane compounds
US4353900A (en) * 1981-10-19 1982-10-12 Syntex (U.S.A.) Inc. 9-(Arylalkyl or aroylalkyl)-1-oxa-4,9-diazaspiro(5.5)undecan-3-ones
WO1993013101A1 (en) * 1991-12-27 1993-07-08 Yoshitomi Pharmaceutical Industries, Ltd. Pyridonecarboxylate compound, pharmaceutical use thereof, and spiro compound
US6114541A (en) 1997-03-10 2000-09-05 Hoffmann-La Roche Inc. Method for the preparation of α-Bromo-Lactam derivatives
CN101050215A (zh) 2001-12-28 2007-10-10 阿卡蒂亚药品公司 作为单胺受体调节剂的螺氮杂环化合物
DE602004029786D1 (de) * 2003-06-30 2010-12-09 Koninkl Philips Electronics Nv Verbesserung der qualität von dekodierten audio mittels hinzufügen von geräusch
EP1634873A1 (en) 2004-08-27 2006-03-15 Laboratorios Del Dr. Esteve, S.A. Sigma receptor inhibitors
DE102005030051A1 (de) 2005-06-27 2006-12-28 Grünenthal GmbH Substituierte 1-Oxa-3,8-diazaspiro[4,5]-decan-2-on-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
JP5217438B2 (ja) * 2005-11-18 2013-06-19 小野薬品工業株式会社 塩基性基を含有する化合物およびその用途
EP1829869A1 (en) 2006-03-02 2007-09-05 Laboratorios Del Dr. Esteve, S.A. 4,5,6,7-Tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands
WO2007124136A1 (en) * 2006-04-19 2007-11-01 Acadia Pharmaceuticals, Inc. Use of 4-amino-piperidines for treating sleep disorders
EP1847542A1 (en) 2006-04-21 2007-10-24 Laboratorios del Dr. Esteve S.A. Spiro[benzopyran] or spiro[benzofuran] derivatives which inhibit the sigma receptor
BRPI0808025A2 (pt) 2007-03-01 2014-06-24 Mitsubishi Tanabe Pharma Corp Composto de benzimidazol e uso farmacêutico do mesmo
EP1982714A1 (en) 2007-04-16 2008-10-22 Laboratorios del Dr. Esteve S.A. Pyrano-pyrazole-amines
EP2020414A1 (en) * 2007-06-20 2009-02-04 Laboratorios del Dr. Esteve S.A. spiro[piperidine-4,4'-thieno[3,2-c]pyran] derivatives and related compounds as inhibitors of the sigma receptor for the treatment of psychosis
US20110190280A1 (en) 2007-08-29 2011-08-04 George Adjabeng Thiazole And Oxazole Kinase Inhibitors
EP2070933A1 (en) 2007-12-07 2009-06-17 Laboratorios del Dr. Esteve S.A. Tricyclic triazolic compounds
JP4861305B2 (ja) 2007-12-28 2012-01-25 マブチモーター株式会社 有ブラシｄｃモータのケース蓋組立体
NZ586872A (en) 2008-02-06 2012-03-30 Astrazeneca Ab Spirocyclic amide compounds
EP2686325B1 (en) * 2011-03-14 2016-12-14 Vertex Pharmaceuticals Incorporated Morpholine-spirocyclic piperidine amides as modulators of ion channels
EP2744333B1 (en) * 2011-08-19 2016-10-05 Glaxosmithkline Intellectual Property (No. 2) Limited Fatty acid synthase inhibitors
US9751881B2 (en) * 2013-07-31 2017-09-05 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
JP2017100951A (ja) 2014-04-04 2017-06-08 大正製薬株式会社 オキサゾリジノン及びオキサジナノン誘導体
TWI685497B (zh) 2014-06-02 2020-02-21 西班牙商伊史帝夫製藥公司 具有多重模式抗疼痛活性的１-氧雜-４,９-二氮雜螺十一烷化合物之烷基衍生物
TW201615642A (zh) 2014-06-02 2016-05-01 伊史帝夫博士實驗室股份有限公司 具有多重模式抗疼痛活性的１－氧雜－４，９－二氮雜螺十一烷化合物之醯胺衍生物
TW201615643A (zh) 2014-06-02 2016-05-01 伊史帝夫博士實驗室股份有限公司 具有多重模式抗疼痛活性之１－氧雜－４，９－二氮雜螺十一烷化合物之烷基與芳基衍生物
WO2016078771A1 (en) 2014-11-21 2016-05-26 Laboratorios Del Dr. Esteve, S.A. 1,9-diazaspiro undecane compounds having multimodal activity against pain
EP3365346B1 (en) 2015-10-23 2019-12-04 Esteve Pharmaceuticals, S.A. Oxa-diazaspiro compounds having activity against pain

Also Published As

Publication number Publication date
TW201615643A (zh) 2016-05-01
JP6535687B2 (ja) 2019-06-26
US20170101420A1 (en) 2017-04-13
ES2784250T3 (es) 2020-09-23
CA2949570A1 (en) 2015-12-10
EP3149007B1 (en) 2020-01-08
EP3149007A1 (en) 2017-04-05
CN106459093A (zh) 2017-02-22
US20200339597A1 (en) 2020-10-29
US10703765B2 (en) 2020-07-07
AR100714A1 (es) 2016-10-26
MX2016015762A (es) 2017-04-10
WO2015185207A1 (en) 2015-12-10
JP2017516819A (ja) 2017-06-22

Similar Documents

Publication Publication Date Title
PT3149007T (pt) Derivados de alquilo e arilo de compostos de 1-oxa-4,9-diazaespiro undecano tendo atividade multimodal contra a dor
ZA201608079B (en) Alkyl derivatives of 1-oxa-4,9-diazaspiro undecane compounds having multimodal activity against pain
HRP20181650T1 (hr) Biciklički heterociklički derivati kao inhibitori bromodomene
EP3296708A4 (en) THERMOMETER OF DEEP BODY
EP3191176C0 (en) SYSTEMS AND METHODS FOR EXTENDING THE LIFE OF AN IMPLANTED PULSE GENERATION BATTERY
EP3180065A4 (en) Long-term implantable monitoring system & methods of use
EP3180080A4 (en) Brain stimulation system including multiple stimulation modes
PT3149005T (pt) Derivados de amida de compostos de 1-oxa-4,9-diazaespiro undecano tendo atividade multimodal contra a dor
HK1256795A1 (zh) 可用於治療自身免疫疾病的二吡唑基衍生物
IL251164A0 (en) Imidazo-[4,5-c]pyridine derivatives as inhibitors of ssao
IL247155A0 (en) Rapamycin for the treatment of lymphangioleiomyomatosis
EP2968311A4 (en) OXAZOLO [5,4-C] CHINOLIN-2-ON COMPOUNDS AS BROMODOMENA INHIBITORS
IL244909A0 (en) Rapamycin for the treatment of lymphangioleiomyomatosis
ZA201608442B (en) Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
PL2949650T3 (pl) Syntetyczny sposób otrzymywania 1,2-benzoizotiazolin-3-onu
EP3302485A4 (en) CERDULATINIB FOR THE TREATMENT OF B-CELL MALIGNOMES
IL251166A0 (en) Imidazo-[4,5-c]pyridine derivatives as inhibitors of ssao
ZA201606921B (en) Use of xanthophylls for the treatment of cancers